Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis (Q38987093)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

8 September 2017

0 references

Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis (English)

1 reference

Europe PubMed Central

8 September 2017

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Remo Panaccione

7

object named as

Remo Panaccione

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

Stephanie Coward

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M Ellen Kuenzig

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fiona Clement

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Kerry McBrien

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Rebecca Holmes

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Cynthia H Seow

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Ali Rezaie

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gilaad G Kaplan

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

31 January 2017

1 reference

Europe PubMed Central

8 September 2017

Inflammatory Bowel Diseases

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

461-472

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

The global burden of IBD: from 2015 to 2025.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Inflammatory bowel disease: a Canadian burden of illness review

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Management of Crohn's disease in adults.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

5-Aminosalicylic acid (mesalazine) use in Crohn's disease: a survey of the opinions and practice of Australian gastroenterologists

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Bayesian methods for evidence synthesis in cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Checking consistency in mixed treatment comparison meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Efficacy of 5-aminosalicylates in Crohn's disease: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

A comparison of budesonide and mesalamine for active Crohn's disease. International Budesonide-Mesalamine Study Group.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Budesonide 9 mg is at least as effective as mesalamine 4.5 g in patients with mildly to moderately active Crohn's disease

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Efficacy and tolerability of oral budesonide in Japanese patients with active Crohn's disease: a multicentre, double-blind, randomized, parallel-group Phase II study.

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Oral budesonide for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Analysis of the therapeutic efficacy of different doses of budesonide in patients with active Crohn's ileocolitis depending on disease activity and localization

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0000000000001023

21 January 2018

Identifiers

10.1097/MIB.0000000000001023

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28146003%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38987093&oldid=1981066227"